Odile Y Leroy, MD, MPH, is the Executive Director of the European Vaccine Initiative. Graduated as physician, clinical pharmacologist, epidemiologist, and public health, she started her carrier in Pharmacovigilance in Bordeaux (France) in 1978. As physician she worked in Cote d’Ivoire and Senegal. In Senegal she was doing research on the implementation of tetanus vaccination in pregnant women in Senegal, and on maternal and infant mortality determinants.
From 1990 to 2000 she was Corporate Clinical Director at Sanofi Pasteur under Prof Stanley Plotkin leadership, responsible for the clinical development of airborne vaccines.
Since 2002 she has been leading European organizations: European Malaria Vaccine Initiative (2002-2004), European Developing Countries Clinical Trial Partnership (2005-2006), and European Vaccine Initiative (EVI) (2007-now).
She is a member of the board of the International Society of Vaccine, since inception member of the malaria vaccine funders group, member of the scientific board of the Global Immunization and Vaccine Research Forum (WHO/NIH/Bill Melinda Gates Foundation), and member of the Steering Committee of the Vaccine Program at Institut Pasteur Paris (France).
In the last ten years she has organized more than 20 workshops addressing harmonization on immune-assays, safety assessment, big data, system biology, animal models, adjuvant, human challenge trials, etc ... She is leading the European Vaccine Research and Development Infrastructure TRANSVAC, designing the Roadmap for European Vaccine R&D Infrastructure and the Roadmap for European Vaccine R&D Innovation